{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:55:40Z","timestamp":1774954540540,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A series of 3,4\u2010dimethoxybenzene\u2010based fibrate derivatives were designed and synthesized, which were screened for preliminary lipid\u2010lowering activity in a Triton WR\u20101339\u2010induced hyperlipidemic mouse model. T5 had the strongest triglyceride (TG) and total cholesterol (TC) lowering effect among these target compounds. In a dose\u2010dependent study, the lowering effects of T5 on TG and TC were progressively enhanced with increasing doses administered. Further studies revealed that T5 had a hypolipidemic significant effect on high\u2010fat diet (HFD)\u2010induced hyperlipidemia mouse model, with substantial reductions in TG, TC, and low\u2010density lipoprotein cholesterol (LDL\u2010C) levels, and a significant reduction in aspartate transaminase (AST) and alanine aminotransferase (ALT) levels in the liver, which had a protective effect on the liver. The of liver pathology showed that T5 could effectively inhibit lipid accumulation as well as inflammatory infiltration in the liver, thus reducing the degree of liver tissue damage. The expression of peroxisome proliferator\u2010activated receptor\u2010\u03b1 (PPAR\u2010\u03b1), which regulates lipid metabolism, was significantly upregulated in liver tissues. Molecular docking assays also confirmed the high binding affinity between T5 and PPAR\u2010\u03b1 active sites. In addition, T5 exhibited significant anti\u2010inflammatory and antioxidant effects. These findings suggest that T5 has multiple activities and may be a potential novel hypolipidemic drug with hypolipidemic and hepatoprotective effects.<\/jats:p>","DOI":"10.1111\/cbdd.70123","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:06:41Z","timestamp":1747984001000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Design and Synthesized 3,4\u2010Dimethoxybenzene\u2010Based Fibrate Derivatives as Potential Hypolipidemic and Liver Protection Agents"],"prefix":"10.1111","volume":"105","author":[{"given":"Ling","family":"Ding","sequence":"first","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyu","family":"An","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Shi","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizi","family":"Shangguan","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"},{"name":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine Shaanxi Administration of Traditional Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiping","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"},{"name":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine Shaanxi Administration of Traditional Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongheng","family":"Shi","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"},{"name":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine Shaanxi Administration of Traditional Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinya","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"},{"name":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine Shaanxi Administration of Traditional Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9358-4864","authenticated-orcid":false,"given":"Yundong","family":"Xie","sequence":"additional","affiliation":[{"name":"College of Pharmacy Shaanxi University of Chinese Medicine  Xianyang People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28025"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666190523123357"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2013.533"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179727"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2022.0023"},{"key":"e_1_2_11_7_1","unstructured":"Dai R. Y.Chen C.Dend L.Tang H.Liang andDAI R (DAIR\u2010Individual). n.d.\u201cDevelopment of High Triglyceride Acute Pancreatitis Model of Rat Involves Selecting Male Sprague\u2010Dawley Rats Feeding Into Hyperlipidemia and Intra\u2010Arterially Injecting Free Fatty Acid to Rats to Induce Acute Pancreatitis Patent CN104146993\u2010A.\u201d"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/1386207324666210628114216"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.4161\/derm.3.1.14615"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/qsar.19880070403"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf071868c"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.4268\/cjcmm20162002"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2022.8534"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044\u2010009\u20109217\u20105"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.104404"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm2014293"},{"key":"e_1_2_11_17_1","unstructured":"Liu L. J.Guan Y.Zhao L.Zhao Y.Wang andChiatai Qingchunbao Pharm Co Ltd. n.d.\u201cUse of Senkyunolide I for Treating Hyperlipidemia and\/or Hyperlipidemia Complication Where Hyperlipidemia Includes Hypercholesterolemia Hypertriglyceridemia Mixed Hyperlipidemia or Low High\u2010Density Lipoproteinemia and Hyperlipidemia Complication Includes Fatty Liver or Alzheimer's Disease Patent CN115581694\u2010A.\u201d"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122378"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883\u2010025\u201001292\u20100"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2019.09.007"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1142\/s0217984921300027"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1089\u20103261(03)00024\u20102"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044\u2010024\u201003214\u20102"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574884712666171108103325"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883\u2010021\u201000918\u20103"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130116"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2025.115801"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7964318"},{"key":"e_1_2_11_29_1","first-page":"885","article-title":"Antilipidemic Drugs. 1. Synthesis and Structure\u2010Activity Relationship of New Alcoyl and Benzoyl Phenoxy Carboxylic\u2010Acids","volume":"26","author":"Sornay R.","year":"1976","journal-title":"Arzneimittel\u2010Forschung\/Drug Research"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177306"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.49.442"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044\u2010024\u201003216\u20100"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.127898"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196657"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813942"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101400"},{"key":"e_1_2_11_37_1","unstructured":"Zhao Z. G.Wu Y.Xi et\u00a0al. n.d.\u201cUse of Naringin in Preparing Medicine for Preventing or Treating Drug Induced Liver Injury for Reducing Level of Reactive Oxygen Species in Hepatocytes Inhibiting Inflammatory Reaction and Apoptosis Patent CN115154477\u2010A.\u201d"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cbdd.70123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:12:00Z","timestamp":1748412720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cbdd.70123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/cbdd.70123"],"URL":"https:\/\/doi.org\/10.1111\/cbdd.70123","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2025-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70123"}}